Arie Belldegrun - 26 Mar 2021 Form 4/A - Amendment Insider Report for UroGen Pharma Ltd. (URGN)

Role
Director
Signature
/s/ Jason Smith, Attorney-in-Fact
Issuer symbol
URGN
Transactions as of
26 Mar 2021
Net transactions value
+$16,205
Form type
4/A - Amendment
Filing time
09 Jun 2021, 13:47:07 UTC
Date Of Original Report
22 Apr 2021
Next filing
25 May 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction URGN Ordinary Shares Options Exercise $16,205 +3,241 +1.3% $5.00 245,452 26 Mar 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction URGN Stock Option (right to buy) Options Exercise $0 -3,241 -100% $0.000000* 0 26 Mar 2021 Ordinary Shares 3,241 $5.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On April 22, 2021, the reporting person filed a Form 4 that mistakenly listed the transaction date as March 24, 2021.